I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 11 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 21% ± 5% | |
| B cell | 9 studies | 17% ± 1% | |
| CD8-positive, alpha-beta T cell | 9 studies | 22% ± 9% | |
| regulatory T cell | 8 studies | 20% ± 9% | |
| macrophage | 7 studies | 20% ± 4% | |
| endothelial cell | 7 studies | 19% ± 4% | |
| non-classical monocyte | 6 studies | 19% ± 4% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 18% ± 4% | |
| monocyte | 5 studies | 26% ± 6% | |
| naive B cell | 5 studies | 20% ± 5% | |
| microglial cell | 5 studies | 22% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 25% ± 12% | |
| dendritic cell | 4 studies | 22% ± 5% | |
| alveolar macrophage | 4 studies | 23% ± 6% | |
| memory B cell | 4 studies | 18% ± 3% | |
| plasma cell | 3 studies | 28% ± 7% | |
| classical monocyte | 3 studies | 19% ± 3% | |
| conventional dendritic cell | 3 studies | 23% ± 6% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| glomerular endothelial cell | 3 studies | 17% ± 0% | |
| lymphocyte | 3 studies | 20% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 25% ± 5% |
